Botulinum toxin type A in the management of lower urinary tract symptoms due to benign prostatic hyperplasia.

Trial Profile

Botulinum toxin type A in the management of lower urinary tract symptoms due to benign prostatic hyperplasia.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 23 Apr 2012

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Apr 2012 New source identified and integrated (ClinicalTrials.gov).
    • 23 Apr 2012 Status changed from not stated to completed, acording to the ClinicalTrials.gov record..
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top